T-Cell and NK-Cell Neoplasm — Trials

T-Cell and NK-Cell Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,103 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–39 of 39 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07758491	A Phase I/II Study of FG-M131 in TRBC1+ Relapsed/Refractory Peripheral T-Cell Lymphoma	not yet recruiting	Phase 1 / Phase 2	110	FutureGen Biopharmaceutical (Beijing) Co., LtdINDUSTRY	1	Sep 2, 2026	clinicaltrials
NCT07791615	A Phase II Study of Stapokibart Combined With Immune Checkpoint Inhibitors in Relapsed/Refractory Lymphoma	not yet recruiting	Phase 2	20	Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER	0